Clinical Trial Update: Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study evaluates HS-10241 in subjects with hepatic impairment and normal hepatic function to inform dosing for advanced non-small ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• HS-10241

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Advanced Non-small Cell Lung Cancer | Phase 1 | Status: NOT_YET_RECRUITING